Why CBD Manufacturers Should Develop GMPs Even if Absent FDA Instructions
May 13, 2024
Cannabidiol (CBD) is the latest “it” product. Companies across the US and internationally are
Cannabidiol (CBD) is the latest “it” product. Companies across the US and internationally are
The following is a redacted transcript of a live conference call question and
As a plant-floor engineer, I’ve witnessed the inner workings of pharmaceuticals, medical devices,
FDA inspection readiness is always a hot topic within the life sciences industry.
Quality culture, a term that has been gaining traction in regulatory compliance, is
In the realm of regulatory compliance, one acronym consistently looms large: CAPA or
The FDA and other global regulators rely on data reviews during inspections to determine whether a
In the realm of quality and compliance within pharmaceuticals, biopharmaceuticals, and combination products,
Attention life science quality and compliance professionals. Mark your calendars for this Thursday,
The CDMO and CMO relationships and the whole kind of business dynamic is
© 2009-2025 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.
